From GlobeNewswire:

Prime Medicine, Inc. will give a corporate overview at the 42nd Annual J.P. Morgan Healthcare Conference on January 8, 2024. The live audio webcast can be found on the Company’s website. Prime Medicine focuses on developing gene editing therapies with its proprietary Prime Editing platform, with 18 programs currently in progress. The Company aims to provide potentially curative therapeutic options for a broad range of diseases. For more information, visit www.primemedicine.com.



Read more: Prime Medicine to Present at 42nd Annual J.P. Morgan